Medicare eligibility

.

Chapter 4 in Cost-Benefit Analysis and Dementia, 2022, pp 50-66 from Edward Elgar Publishing

Abstract: The second new dementia intervention is Medicare eligibility. Medicare provides extra services for those with dementia. We still are using costs savings to caregivers from the transfer to independent living as the ultimate measure of benefits. The difference is that the transfer is larger now because of the increased Quality of Life (QoL) following from Medicare eligibility. Our quantitative measure for the QoL is the Geriatric Dementia Scale (GDS) short form. The services associated with Medicare's four parts are covered and the ingredients of the GDS are listed. Regression Discontinuity is relied upon as the causal strategy for explaining why dementia symptoms fall precisely when a person turns 65 and is Medicare eligible. The dementia benefits of being Medicare eligible are $9,338 per person. The additional cost to Medicare if someone's dementia symptoms is not reduced is $6,540. The net-benefits are $2,798 per person, making Medicare eligibility worthwhile.

Keywords: Development Studies; Economics and Finance; Environment; Sociology and Social Policy (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.elgaronline.com/view/9781839105753.00013.xml (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:19697_4

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().